Lv62
2166 积分 2022-06-06 加入
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
1小时前
待确认
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
1天前
待确认
Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung cancer patients
11天前
已完结
A Review of Congenital Internal Abdominal Hernias
1个月前
已关闭
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors
2个月前
已完结
C-KIT Negative Gastrointestinal Stromal Tumors: Challenges of Management and Prognosis
2个月前
已关闭
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
2个月前
已完结
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
2个月前
已完结
74MO Impact of MTAP loss on prognosis and efficacy of immune check point inhibitors across advanced solid tumors: SCRUM-Japan MONSTAR-SCREEN-1
2个月前
已完结
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
3个月前
已完结
皖公网安备34019202002308
